Arthur Tzianabos, Director: Stoke Therapeutics STOK Planned sale · Filed 03/10

Trade details

Type: Planned sale notice
Stock: Stoke Therapeutics STOK
Person: Arthur TzianabosDirector
Planned sale date: 26/03/10
Filed: 26/03/10

0.2% of shares outstanding to be sold

Stoke Therapeutics trades, last 26 weeks

What else happened in Stoke Therapeutics around then

Filed or reported within 30 days of the trade day · 02/08~04/09

Arthur Tzianabos's recent trades

Arthur TzianabosInterim Executive Chair
Sell10b5-1 planStoke Therapeutics
Sell10b5-1 plan
Stoke Therapeutics
STOK
$174.2K
4,355 sh
$174.2K
Filed 03/12
Traded 03/10
Arthur TzianabosDirector
SellQ32 Bio
Sell
Q32 Bio
QTTB
$6,413
265 sh
$6,413
Filed 24/08/14
Traded 24/03/25
Arthur TzianabosDirector
Sell10b5-1 planQ32 Bio
Sell10b5-1 plan
Q32 Bio
QTTB
$7,431
13,037 sh
$7,431
Filed 24/02/15
Traded 24/01/09
Arthur TzianabosDirector
SellQ32 Bio
Sell
Q32 Bio
QTTB
$14.8K
10,616 sh
$14.8K
Filed 23/01/11
Traded 23/01/09